At the time of writing, Theratechnologies Inc [THTX] stock is trading at $1.48, up 4.96%. An important factor to consider is whether the stock is rising or falling in short-term value. The THTX shares have lost -1.33% over the last week, with a monthly amount drifted -4.52%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Theratechnologies Inc [NASDAQ: THTX] stock has seen the most recent analyst activity on November 17, 2022, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $9. Previously, Canaccord Genuity downgraded its rating to Hold on July 29, 2021, and dropped its price target to $3.
For the past year, the stock price of Theratechnologies Inc fluctuated between $1.08 and $2.18. Theratechnologies Inc [NASDAQ: THTX] shares were valued at $1.48 at the most recent close of the market.
Analyzing the THTX fundamentals
According to Theratechnologies Inc [NASDAQ:THTX], the company’s sales were 85.87M for trailing twelve months, which represents an 6.61% jump. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.1%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is 0.36 and Total Capital is 0.5. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3933 points at the first support level, and at 1.3067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5533, and for the 2nd resistance point, it is at 1.6267.
Ratios To Look Out For
It is important to note that Theratechnologies Inc [NASDAQ:THTX] has a current ratio of 1.19. On the other hand, the Quick Ratio is 1.05, and the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 0.42.
